1. Mae, Hirokazu, Outani, Hidetatsu, Imura, Yoshinori, Takenaka, Satoshi, Okada, Seiji. 2023. Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition. In Cancer research communications, 3, 1152-1165. doi:10.1158/2767-9764.CRC-22-0518. https://pubmed.ncbi.nlm.nih.gov/37405123/
2. Li, Bingbing X, David, Larry L, Davis, Lara E, Xiao, Xiangshu. 2022. Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma. In The Journal of biological chemistry, 298, 102434. doi:10.1016/j.jbc.2022.102434. https://pubmed.ncbi.nlm.nih.gov/36041632/
3. Thway, Khin, Fisher, Cyril. . Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. In The American journal of surgical pathology, 36, e1-e11. doi:10.1097/PAS.0b013e31825485c5. https://pubmed.ncbi.nlm.nih.gov/22510762/
4. Sánchez-Mir, Laura, Salat-Canela, Clàudia, Paulo, Esther, Oliva, Baldo, Hidalgo, Elena. 2017. Phospho-mimicking Atf1 mutants bypass the transcription activating function of the MAP kinase Sty1 of fission yeast. In Current genetics, 64, 97-102. doi:10.1007/s00294-017-0730-7. https://pubmed.ncbi.nlm.nih.gov/28799013/
5. Rangaraju, Srikant, Dammer, Eric B, Raza, Syed Ali, Seyfried, Nicholas T, Levey, Allan I. 2018. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. In Molecular neurodegeneration, 13, 24. doi:10.1186/s13024-018-0254-8. https://pubmed.ncbi.nlm.nih.gov/29784049/
6. Komura, Shingo, Ito, Kenji, Ohta, Sho, Yamamoto, Takuya, Yamada, Yasuhiro. 2019. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas. In Nature communications, 10, 3999. doi:10.1038/s41467-019-11745-1. https://pubmed.ncbi.nlm.nih.gov/31488818/
智鼠故事 
